Phoslock Environmental Technologies (ASX:PET) Licenses Its Brand to a US Distributor and Books 100-Tonne Orders

Aditi Sarkar

28 October 2026 04:22 PM AEDT

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

The Orion Companies may use the Phoslock trademark to market and sell certain new products in the United States.
The company will receive 10 per cent of Orion's gross profit from those products, expecting immaterial income initially.
New purchase orders for about 100 tonnes bring year-to-date sales to Orion to 158 tonnes.
The distribution agreement expires in December 2026, and a two-year extension is under negotiation but not agreed.

A famous product name is now a licensed brand in the United States. Phoslock Environmental Technologies Limited (ASX:PET) said on 28 October 2026 that it has licensed The Orion Companies (TOC) to use the Phoslock trademark for marketing and selling certain new products there. TOC also placed new orders for about 100 tonnes of Phoslock for immediate delivery. The update contained no revenue, cash or earnings guidance figures.

The licence

TOC may use the trademark to market and sell some new products in the United States, and may buy Phoslock from the company to blend and repackage for sale there. In return, Phoslock Environmental Technologies will receive 10 per cent of TOC's gross profit from these products. The company does not expect the income to be material initially.

The announcement does not name the new products or give a start date or a minimum volume.

New orders and the distribution agreement

TOC placed purchase orders under the existing distribution agreement for about 100 tonnes of Phoslock, for immediate delivery. With these orders, year-to-date sales to TOC would reach 158 tonnes. No order value was given.

The current United States distribution agreement with the Orion group expires in December 2026. The company is negotiating a two-year extension, but no terms have been agreed, so it remains a proposal.

Product development

A 700 kilogram application of Phoslock 10 has been made to a pond in China, and results are being monitored. Batch production of Phoslock 10 and Phoslock 20 is under way, together with bulk pond testing. Pond applications in other jurisdictions are proposed but not finalised.

The company is also developing new phosphorus-binding products with higher lanthanum content for the global market.

What is confirmed and what is not

Phoslock is a lanthanum-modified clay used to bind phosphorus in water bodies, and the business depends on repeat orders from distributors in each region. The US update combines a new royalty-style licence income stream, a volume order from an existing distributor and a renewal yet to be agreed.

The value of the 100-tonne order is not disclosed, the renewal is still under negotiation, and the China pond trial and proposed applications elsewhere have no reported results. The company gave no timetable beyond the December 2026 expiry date and no dates for results from batch production and bulk pond testing.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.